Relmada Therapeutics, Inc.
Pharmaceutical company · Coral Gables, Florida, United States · Nasdaq: RLMD
Relmada Therapeutics, Inc. is a pharmaceutical company headquartered in Coral Gables, Florida, United States. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker RLMD. It has reported private securities offerings to the US SEC, most recently $825,750 sold in a notice filed in 2019.
Relmada Therapeutics at a glance
What does Relmada Therapeutics do?
Private fundraising reported to the SEC
14 Form D notices; the most recent reported $825,750 sold (2019).
Frequently asked questions about Relmada Therapeutics
Where is Relmada Therapeutics headquartered?
Relmada Therapeutics, Inc. is headquartered in Coral Gables, Florida, United States.
What does Relmada Therapeutics do?
Relmada Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Relmada Therapeutics a public company?
Yes. Relmada Therapeutics, Inc. trades on Nasdaq under the ticker RLMD.
When was Relmada Therapeutics founded?
The earliest incorporation on record for Relmada Therapeutics, Inc. is in 2012, according to public company registers.
Similar companies
- Catalyst Pharmaceuticals, Inc.Coral Gables, Florida, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences